These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29549945)

  • 21. RVG-peptide-linked trimethylated chitosan for delivery of siRNA to the brain.
    Gao Y; Wang ZY; Zhang J; Zhang Y; Huo H; Wang T; Jiang T; Wang S
    Biomacromolecules; 2014 Mar; 15(3):1010-8. PubMed ID: 24547943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptides as a therapeutic avenue for nanocarrier-aided targeting of glioma.
    Wanjale MV; Kumar GSV
    Expert Opin Drug Deliv; 2017 Jun; 14(6):811-824. PubMed ID: 27690671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug delivery across the blood-brain barrier: recent advances in the use of nanocarriers.
    Mulvihill JJ; Cunnane EM; Ross AM; Duskey JT; Tosi G; Grabrucker AM
    Nanomedicine (Lond); 2020 Jan; 15(2):205-214. PubMed ID: 31916480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transvascular delivery of small interfering RNA to the central nervous system.
    Kumar P; Wu H; McBride JL; Jung KE; Kim MH; Davidson BL; Lee SK; Shankar P; Manjunath N
    Nature; 2007 Jul; 448(7149):39-43. PubMed ID: 17572664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptides and Drug Delivery.
    Ulapane KR; Kopec BM; Moral MEG; Siahaan TJ
    Adv Exp Med Biol; 2017; 1030():167-184. PubMed ID: 29081054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application progress of RVG peptides to facilitate the delivery of therapeutic agents into the central nervous system.
    Wang Q; Cheng S; Qin F; Fu A; Fu C
    RSC Adv; 2021 Feb; 11(15):8505-8515. PubMed ID: 35423368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug Delivery to the Brain across the Blood-Brain Barrier Using Nanomaterials.
    Tsou YH; Zhang XQ; Zhu H; Syed S; Xu X
    Small; 2017 Nov; 13(43):. PubMed ID: 29045030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The proton permeability of self-assembled polymersomes and their neuroprotection by enhancing a neuroprotective peptide across the blood-brain barrier after modification with lactoferrin.
    Yu Y; Jiang X; Gong S; Feng L; Zhong Y; Pang Z
    Nanoscale; 2014 Mar; 6(6):3250-8. PubMed ID: 24503971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer's disease mice.
    Liu Y; An S; Li J; Kuang Y; He X; Guo Y; Ma H; Zhang Y; Ji B; Jiang C
    Biomaterials; 2016 Feb; 80():33-45. PubMed ID: 26706474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polyion complex micelles composed of pegylated polyasparthydrazide derivatives for siRNA delivery to the brain.
    Huo H; Gao Y; Wang Y; Zhang J; Wang ZY; Jiang T; Wang S
    J Colloid Interface Sci; 2015 Jun; 447():8-15. PubMed ID: 25689522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting caspase-3 as dual therapeutic benefits by RNAi facilitating brain-targeted nanoparticles in a rat model of Parkinson's disease.
    Liu Y; Guo Y; An S; Kuang Y; He X; Ma H; Li J; Lu J; Zhang N; Jiang C
    PLoS One; 2013; 8(5):e62905. PubMed ID: 23675438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoparticle-derived non-viral genetic transfection at the blood-brain barrier to enable neuronal growth factor delivery by secretion from brain endothelium.
    Thomsen LB; Larsen AB; Lichota J; Moos T
    Curr Med Chem; 2011; 18(22):3330-4. PubMed ID: 21728969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in delivery through the blood-brain barrier.
    Larsen JM; Martin DR; Byrne ME
    Curr Top Med Chem; 2014; 14(9):1148-60. PubMed ID: 24678707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nano-enabled delivery systems across the blood-brain barrier.
    Hwang SR; Kim K
    Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptide-decorated nanocarriers penetrating the blood-brain barrier for imaging and therapy of brain diseases.
    Gao X; Xu J; Yao T; Liu X; Zhang H; Zhan C
    Adv Drug Deliv Rev; 2022 Aug; 187():114362. PubMed ID: 35654215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide pills for brain diseases? Reality and future perspectives.
    Serrano Lopez DR; Lalatsa A
    Ther Deliv; 2013 Apr; 4(4):479-501. PubMed ID: 23557289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The battle of lipid-based nanocarriers against blood-brain barrier: a critical review.
    Abla KK; Mehanna MM
    J Drug Target; 2023 Sep; 31(8):832-857. PubMed ID: 37577919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cre Fused with RVG Peptide Mediates Targeted Genome Editing in Mouse Brain Cells In Vivo.
    Zou Z; Sun Z; Li P; Feng T; Wu S
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27983648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanocarriers for Effective Brain Drug Delivery.
    Comoglu T; Arisoy S; Akkus ZB
    Curr Top Med Chem; 2017; 17(13):1490-1506. PubMed ID: 28017157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
    Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
    J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.